Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators.
Sci Rep
; 8(1): 14604, 2018 10 02.
Article
in En
| MEDLINE
| ID: mdl-30279487
ABSTRACT
In view of the role of sEH (soluble epoxide hydrolase) in hypertension, we have developed a rigorously validated pharmacophore model containing one HBA (Hydrogen Bond Acceptor), two HY (Hydrophobic) and one RA (Ring Aromatic) features. The model was used as a query to search the NCI (National Cancer Institute) and Maybridge database leading to retrieval of many compounds which were sorted on the basis of predicted activity, fit value and Lipinski's violation. The selected compounds were docked into the active site of enzyme soluble epoxide hydrolase. Potential interactions were observed between the features of the identified hits and the amino acids present in the docking site. The three selected compounds were subjected to in vitro evaluation using enzyme- based assay and the isolated rat aortic model followed by cytotoxicity studies. The results demonstrate that the identified compounds are potent, safe and novel soluble epoxide hydrolase inhibitors.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aorta
/
Vasodilation
/
Vasodilator Agents
/
Enzyme Inhibitors
/
Epoxide Hydrolases
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Sci Rep
Year:
2018
Document type:
Article
Affiliation country:
India